Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1782-1791

  Becker, Christian M ^a,b   Beaudry, Paul ^a,c   Funakoshi, Tae ^a,d   Benny, Ofra ^a   Zaslavsky, Alexander ^a,e   Zurakowski, David ^a   Folkman, Judah ^a   D'Amato, Robert J ^a   Ryeom, Sandra ^a,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d TOTTORI UNIVERSITY   (Japan)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; GREEN FLUORESCENT PROTEIN; LODAMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; STEM CELL; UPREGULATION;

EID: 79953664421     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.037     Document Type: Article

References (77)

1. Cramer DW, Missmer SA: The epidemiology of endometriosis. Ann NY Acad Sci 2002, 955:11-22; discussion 34-16, 396-406
2. Bulun SE: Endometriosis. N Engl J Med 2009, 360:268-279
3. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E: ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005, 20:2698-2704 (Pubitemid 41487622)
4. Kennedy S, Hadfield R, Mardon H, Barlow D: Age of onset of pain symptoms in non-twin sisters concordant for endometriosis. Hum Reprod 1996, 11:403-405 (Pubitemid 26089195)
5. Simoens S, Hummelshoj L, D'Hooghe T: Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007, 13:395-404 (Pubitemid 47062831)
6. Zhao SZ, Wong JM, Davis MB, Gersh GE, Johnson KE: The cost of inpatient endometriosis treatment: an analysis based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. Am J Manag Care 1998, 4:1127-1134 (Pubitemid 28405519)
7. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A: Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997, 176:572-579 (Pubitemid 27147164)
8. Varma R, Rollason T, Gupta JK, Maher ER: Endometriosis and the neoplastic process. Reproduction 2004, 127:293-304 (Pubitemid 38425689)
9. Becker CM, D'Amato RJ: Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 2007, 74:121-130 (Pubitemid 350051024)
10. Taylor RN, Lebovic DI, Mueller MD: Angiogenic factors in endometriosis. Ann NY Acad Sci 2002, 955:89-100; discussion 118, 396-406
11. Taylor RN, Mueller MD: Anti-angiogenic treatment of endometriosis: biochemical aspects. Gynecol Obstet Invest 2004, 57:54-56 (Pubitemid 38186438)
12. Becker CM, Sampson DA, Rupnick MA, Rohan RM, Efstathiou JA, Short SM, Taylor GA, Folkman J, D'Amato RJ: Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril 2005, 84(Suppl 2):1144-1155 (Pubitemid 41396540)
13. Dabrosin C, Gyorffy S, Margetts P, Ross C, Gauldie J: Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathol 2002, 161:909-918 (Pubitemid 34988378)
14. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD: Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006, 21:262-268 (Pubitemid 41794320)
15. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, Groothuis PG: Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004, 89:1089-1095 (Pubitemid 38368395)
16. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936
17. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967 (Pubitemid 27087709)
18. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R: Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 2005, 102:18111-18116 (Pubitemid 41798510)
19. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M: Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998, 13:1686-1690 (Pubitemid 28310515)
20. McLaren J, Prentice A, Charnock-Jones DS, Smith SK: Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996, 11:220-223 (Pubitemid 26047702)
21. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN: Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996, 81:3112-3118 (Pubitemid 26323917)
22. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18:3964-3972 (Pubitemid 29335849)
23. Xavier P, Belo L, Beires J, Rebelo I, Martinez-de-Oliveira J, Lunet N, Barros H: Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006, 273:227-231 (Pubitemid 43004695)
24. Gagne D, Page M, Robitaille G, Hugo P, Gosselin D: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 2003, 18:1674-1680 (Pubitemid 36958049)
25. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
26. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198
27. Kerbel RS, Benezra R, Lyden DC, Hattori K, Heissig B, Nolan DJ, Mittal V, Shaked Y, Dias S, Bertolini F, Rafii S: Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas. Proc Natl Acad Sci USA 2008, 105:E54; author reply E55
28. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201 (Pubitemid 33063774)
29. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P: Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 2008, 105:6620-6625 (Pubitemid 351754556)
30. Beaudry P, Force J, Naumov GN, Wang A, Baker CH, Ryan A, Soker S, Johnson BE, Folkman J, Heymach JV: Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res 2005, 11:3514-3522 (Pubitemid 40627906)
31. Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS: Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005, 7:101-111 (Pubitemid 40126386)
32. Udagawa T, Puder M, Wood M, Schaefer BC, D'Amato RJ: Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J 2006, 20:95-102 (Pubitemid 43100480)
33. Becker CM, Sampson DA, Rupnick MA, Rohan RM, Efstathiou JA, Short SM, Taylor GA, Folkman J, D'Amato RJ: Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril 2005, 84(Suppl 2):1144-1155 (Pubitemid 41396540)
34. Becker CM, Sampson DA, Short SM, Javaherian K, Folkman J, D'Amato RJ: Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril 2006, 85:71-77 (Pubitemid 43063425)
35. Cummings AM, Metcalf JL: Induction of endometriosis in mice: a new model sensitive to estrogen. Reprod Toxicol 1995, 9:233-238
36. Vernon MW, Wilson EA: Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985, 44:684-694 (Pubitemid 16199664)
37. Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J, D'Amato RJ: 2-Methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis, Am J Pathol 2008, 172:534-544 (Pubitemid 351282038)
38. Becker CM, Wright RD, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung AL, D'Amato RJ: A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol 2006, 168:2074-2084 (Pubitemid 43825325)
39. Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L, Adini I, Pravda E, Nahmias Y, Koirala S, Corfas G, D'Amato RJ, Folkman J: An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nature Biotechnol 2008, 26:799-807 (Pubitemid 351961454)
40. Beaudry P, Hida Y, Udagawa T, Alwayn IP, Greene AK, Arsenault D, Folkman J, Heymach JV, Ryeom S, Puder M: Endothelial progenitor cells contribute to accelerated liver regeneration. J Pediatr Surg 2007, 42:1190-1198 (Pubitemid 47017289)
41. Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS: Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 2003, 63:4342-4346 (Pubitemid 36951001)
42. Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, Eder JP Jr, Folkman J, Soker S: Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 2003, 63:8345-8350 (Pubitemid 37549488)
43. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR, Folkman J: Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA 1997, 94:861-866 (Pubitemid 27074412)
44. Bertolini F, Shaked Y, Mancuso P, Kerbel RS: The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006, 6:835-845 (Pubitemid 44629895)
45. Cabral HJ: Multiple comparisons procedures. Circulation 2008, 117:698-701
46. Rohan RM, Fernandez A, Udagawa T, Yuan J, D'Amato RJ: Genetic heterogeneity of angiogenesis in mice. FASEB J 2000, 14:871-876 (Pubitemid 30241663)
47. Taylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD, Sidell N: Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009, 16:140-146
48. Robb AO, Mills NL, Smith IB, Short A, Tura-Ceide O, Barclay GR, Blomberg A, Critchley HO, Newby DE, Denison FC: Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod 2009, 24:619-625
49. Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M: Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2006, 56:79-85
50. Eggermont J, Donnez J, Casanas-Roux F, Scholtes H, Van Langendonckt A: Time course of pelvic endometriotic lesion revascularization in a nude mouse model. Fertil Steril 2005, 84:492-499 (Pubitemid 41125275)
51. Bourlev V, Larsson A, Olovsson M: Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis. Am J Obstet Gynecol 2006, 194:755-759 (Pubitemid 43333151)
52. Ryan IP, Tseng JF, Schriock ED, Khorram O, Landers DV, Taylor RN: Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995, 63:929-932
53. Benjamin LE: The controls of microvascular survival. Cancer Metastasis Rev 2000, 19:75-81
54. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D, Rafii S: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002, 8:841-849
55. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637 (Pubitemid 34628725)
56. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T: Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328 (Pubitemid 36314418)
57. Becker CM, Louis G, Exarhopoulos A, Mechsner S, Ebert AD, Zurakowski D, Moses MA: Matrix metalloproteinases are elevated in the urine of endometriosis patients. Fertil Steril 2010, 94:2343-2346
58. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, Polan ML: Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002, 78:787-795
59. Furuya M, Suyama T, Usui H, Kasuya Y, Nishiyama M, Tanaka N, Ishiwata I, Nagai Y, Shozu M, Kimura S: Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. Hum Pathol 2007, 38:1676-1687 (Pubitemid 47589091)
60. Suzumori N, Sugiura-Ogasawara M, Katano K, Suzumori K: Women with endometriosis have increased levels of placental growth factor in the peritoneal fluid compared with women with cystadenomas. Hum Reprod 2003, 18:2595-2598 (Pubitemid 37536625)
61. D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994, 91:4082-4085 (Pubitemid 24139577)
62. Klauber N, Rohan RM, Flynn E, D'Amato RJ: Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med 1997, 3:443-446 (Pubitemid 27145687)
63. Van Langendonckt A, Donnez J, Defrere S, Dunselman GA, Groothuis PG: Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Mol Hum Reprod 2008, 14:259-268 (Pubitemid 351804027)
64. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990, 348:555-557 (Pubitemid 120015110)
65. Nap AW, Dunselman GA, Griffioen AW, Mayo KH, Evers JL, Groothuis PG: Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril 2005, 83:793-795 (Pubitemid 40348605)
66. Bhargava P, Marshall JL, Rizvi N, Dahut W, Yoe J, Figuera M, Phipps K, Ong VS, Kato A, Hawkins MJ: A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer. Clin Cancer Res 1999, 5:1989-1995 (Pubitemid 29399248)
67. Herbst RS, Madden TL, Tran HT, Blumenschein GR, Jr., Meyers CA, Seabrooke LF, Khuri FR, Puduvalli VK, Allgood V, Fritsche HA, Jr., Hinton L, Newman RA, Crane EA, Fossella FV, Dordal M, Goodin T, Hong WK: Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer. J Clin Oncol 2002, 20:4440-4447 (Pubitemid 35334755)
68. Nahari D, Satchi-Fainaro R, Chen M, Mitchell I, Task LB, Liu Z, Kihneman J, Carroll AB, Terada LS, Nwariaku FE: Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer. Mol Cancer Ther 2007, 6:1329-1337 (Pubitemid 46711996)
69. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM: The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA 1997, 94:6099-6103 (Pubitemid 27270643)
70. Zhang Y, Griffith EC, Sage J, Jacks T, Liu JO: Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci USA 2000, 97:6427-6432 (Pubitemid 30412730)
71. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer 1994, 69:212-216 (Pubitemid 24046539)
72. Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J: Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005, 7:251-261 (Pubitemid 40568684)
73. Yoshida A, Anand-Apte B, Zetter BR: Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 1996, 13:57-64
74. Kaya M, Wada T, Nagoya S, Kawaguchi S, Yamashita T, Yamamoto N, Yoshimoto M, Okada F, Ishii S: TNP-470 Suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells. Sarcoma 2001, 5:197-202 (Pubitemid 34093592)
75. Khakoo AY, Finkel T: Endothelial progenitor cells. Annu Rev Med 2005, 56:79-101 (Pubitemid 40299775)
76. Gargett CE: Uterine stem cells: what is the evidence?. Hum Reprod Update 2007, 13:87-101
77. Efstathiou JA, Sampson DA, Levine Z, Rohan RM, Zurakowski D, Folkman J, D'Amato RJ, Rupnick MA: Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril 2005, 83:171-181 (Pubitemid 40094797)